PD. Dr. rer. physiol. Katja Bieber
Lübeck Institute of Experimental Dermatology
University of Lübeck
Ratzeburger Allee 160
23562 Lübeck
Email: | katja.bieber(at)uni-luebeck.de |
Phone: | +49 451 500 50883 |
Fax: |
Publikationen
1. Stussel P, Schulze Dieckhoff K, Kunzel S, Hartmann V, Gupta Y, Kaiser G, Visser R, Ghorbanalipoor S, Matsumoto K, Krause M, Petersen F, Kalies K, Ludwig RJ and Bieber K. Propranolol Is an Effective Topical and Systemic Treatment Option for Experimental Epidermolysis Bullosa Acquisita. J Invest Dermatol 2020;140:2408-20
2. Kasprick A, Hofrichter M, Smith B, Ward P, Bieber K, Shock A, Ludwig RJ, Schmidt E. Treatment with anti-neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in mice. Br J Pharmacol 2020; 77:2381–2392
3. Vorobyev A, Gupta Y, Sezin T, Koga H, Bartsch Y, Belheouane M, Künzel S, Sina C, Schilf P, Körber-Ahrens H, Beltsiou F, Ernst A, Khilchenko S, Al-Aasam H, Manz R, Diehl S, Steinhaus M, Jascholt J, Kouki P, Boehncke W, Mayadas T, Zillikens D, Sadik C, Nishi H, Ehlers M, Möller S, Bieber K, Baines J, Ibrahim S, Ludwig RJ. Gene-diet interactions associated with complex trait variation in an advanced intercross outbred mouse line. Nat Commun 2019; 10:4097
4. Thieme M, Bieber K, Sezin T, Wannick M, Gupta Y, Kalies K, Ludwig RJ, Mousavi S, Zillikens D, Sadik CD. The Sphingosine-1-Phosphate Receptor Modulator Fingolimod Aggravates Murine Epidermolysis Bullosa Acquisita. J Invest Dermatol 2019; 139:2381-2384
5. Haeberle S, Wei X, Bieber K, Goletz S, Ludwig RJ, Schmidt E, Enk AH, Hadaschik EN. Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease. J Allergy Clin Immunol 2018; 142:1831
6. Tukaj S*, Bieber K*, Witte M, Ghorbanalipoor S, Schmidt E, Zillikens D, Ludwig RJ, Kasperkiewicz M Calcitriol Treatment Ameliorates Inflammation and Blistering in Mouse Models of Epidermolysis Bullosa Acquisita. J Invest Dermatol 2018; 138:301
7. Bieber K*, Sun S*, Witte M, Kasprick A, Beltsiou F, Behnen M, Laskay T, Schulze FS, Pipi E, Reichhelm N, Pagel R, Zillikens D, Schmidt E, Sparwasser T, Kalies K, Ludwig RJ. Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases. Front Immunol 2017;8:1628
8. Bieber K, Ernst AL, Tukaj S, Holtsche MM, Schmidt E, Zillikens D, Ludwig RJ, Kasperkiewicz M. Analysis of serum markers of cellular immune activation in patients with bullous pemphigoid. Exp Dermatol 2017; 26:1248
9. Hirose M, Kasprick A, Beltsiou F, Dieckhoff Schulze K, Schulze FS, Samavedam UK, Hundt JE, Pas HH, Jonkman MF, Schmidt E, Kalies K, Zillikens D, Ludwig RJ*, Bieber K*. Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment. Mol Med 2017; 22:918
10. Bieber K*, Witte M*, Sun S, Hundt JE, Kalies K, Dräger S, Kasprick A, Twelkmeyer T, Manz RA, König P, Köhl J, Zillikens D, Ludwig RJ. T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita. Sci Rep 2016; 6:38357
- Mitglieder
- Leitung
- Projektleiter*innen
- Petra Bacher
- John Baines
- Mareike Becker
- Katja Bieber
- Hauke Busch
- Anke Fähnrich
- Christoph Hammers
- Guido Heine
- Misa Hirose
- Maike Holtsche
- Andreas Hutloff
- Saleh Ibrahim
- Christian Karsten
- Jörg Köhl
- Peter König
- Inke König
- Ralf Ludwig
- Anja Lux
- Rudolf Manz
- Sripriya Murthy
- Falk Nimmerjahn
- Matthias Peipp
- Christian Sadik
- Alexander Scheffold
- Paul Schilf
- Enno Schmidt
- Silke Szymczak
- Nina van Beek
- Martin Väth
- Admar Verschoor
- Nina Wettschureck
- Markus Hoffmann
- Wissenschaftliche Mitarbeiter*innen
- Doktorand*innen
- Ärzt*innen
- Alumni